Status:
RECRUITING
The Effect of Mindfulness-Based Psychoeducation Programme Given Individually to Schizophrenia Patients on Internalised Stigma and Healthy Lifestyle Behaviours
Lead Sponsor:
Kastamonu University
Conditions:
Schizophrenia Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Schizophrenia is a chronic, recurrent and disabling illness that usually lasts a lifetime and causes serious problems in quality of life and functioning. Psychoeducation programmes added to drug treat...
Detailed Description
Research Population/Sample or Study Group: If appropriate in terms of the study method, the population and sample should be explained here. Specify how the sample/study group will be selected, how the...
Eligibility Criteria
Inclusion
- Having been diagnosed with schizophrenia
- TRSM registered and continuing
- Acceptance to work and training
Exclusion
- Have not been diagnosed with schizophrenia
- If he/she does not agree to participate in the study
- If not registered with TRSM
Key Trial Info
Start Date :
February 14 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 15 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06882538
Start Date
February 14 2025
End Date
March 15 2025
Last Update
March 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kastamonu Community Mental Health Centre
Kastamonu, Central, Turkey (Türkiye), 37100